New Targeted Drugs Improve Survival in Advanced Prostate Cancer
Two experimental targeted drugs — radium–223 chloride and MDV3100 — helped some men with difficult–to–treat prostate cancer live longer compared to standard care, according to two international studies.
| • | NCI Cancer Bulletin: new drugs for prostate cancer |
| • | Learn more about prostate cancer treatment |
| • | Targeted Cancer Therapies fact sheet |
Cancer Research News
- UCSF study finds that metabolic profiles are essential for personalizing cancer therapy
- Ohio State study advances understanding of how early breast tumors become deadly
- Salk scientists use an old theory to discover new targets in the fight against breast cancer
Visit the NCI News Center







